4-(4-(4-(5-(((2S,4R)-2-((1H-tetrazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-ayl)methoxy)pyridin-2-yl)piperazin-1-yl)phenyl)-2-(sec-butyl)-2,4-dihydro-3H-1,2,4-triazol-3-one

ID: ALA4647183

Chembl Id: CHEMBL4647183

PubChem CID: 137469587

Max Phase: Preclinical

Molecular Formula: C33H36Cl2N10O4

Molecular Weight: 707.62

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OC[C@@H]5CO[C@@](Cn6cnnn6)(c6ccc(Cl)cc6Cl)O5)cn4)CC3)cc2)c1=O

Standard InChI:  InChI=1S/C33H36Cl2N10O4/c1-3-23(2)45-32(46)44(22-38-45)26-7-5-25(6-8-26)41-12-14-42(15-13-41)31-11-9-27(17-36-31)47-18-28-19-48-33(49-28,20-43-21-37-39-40-43)29-10-4-24(34)16-30(29)35/h4-11,16-17,21-23,28H,3,12-15,18-20H2,1-2H3/t23?,28-,33-/m1/s1

Standard InChI Key:  LOAKYLZGEHLEMW-YTQLCDCXSA-N

Alternative Forms

  1. Parent:

    ALA4647183

    ---

Associated Targets(Human)

CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRKAA2 Tchem AMP-activated protein kinase, AMPK (12273 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MTOR Tclin Serine/threonine-protein kinase mTOR (13850 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDR Tclin Vascular endothelial growth factor receptor 2 (20924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HUVEC (11049 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NPC1 Tchem Niemann-Pick C1 protein (18985 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 707.62Molecular Weight (Monoisotopic): 706.2298AlogP: 4.37#Rotatable Bonds: 11
Polar Surface Area: 130.48Molecular Species: NEUTRALHBA: 14HBD:
#RO5 Violations: 2HBA (Lipinski): 14HBD (Lipinski): #RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 6.73CX LogP: 6.33CX LogD: 6.32
Aromatic Rings: 5Heavy Atoms: 49QED Weighted: 0.19Np Likeness Score: -1.14

References

1. Li Y, Pasunooti KK, Peng H, Li RJ, Shi WQ, Liu W, Cheng Z, Head SA, Liu JO..  (2020)  Design and Synthesis of Tetrazole- and Pyridine-Containing Itraconazole Analogs as Potent Angiogenesis Inhibitors.,  11  (6): [PMID:32550989] [10.1021/acsmedchemlett.9b00438]

Source